Logo image of IEX

IDEX CORP (IEX) Stock Fundamental Analysis

NYSE:IEX - New York Stock Exchange, Inc. - US45167R1041 - Common Stock - Currency: USD

183.38  -0.58 (-0.32%)

After market: 183.38 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to IEX. IEX was compared to 127 industry peers in the Machinery industry. IEX scores excellent on profitability, but there are some minor concerns on its financial health. IEX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

IEX had positive earnings in the past year.
In the past year IEX had a positive cash flow from operations.
Each year in the past 5 years IEX has been profitable.
Each year in the past 5 years IEX had a positive operating cash flow.
IEX Yearly Net Income VS EBIT VS OCF VS FCFIEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

IEX's Return On Assets of 7.05% is fine compared to the rest of the industry. IEX outperforms 66.93% of its industry peers.
IEX has a Return On Equity of 12.26%. This is in the better half of the industry: IEX outperforms 61.42% of its industry peers.
With a decent Return On Invested Capital value of 8.78%, IEX is doing good in the industry, outperforming 60.63% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IEX is in line with the industry average of 10.78%.
Industry RankSector Rank
ROA 7.05%
ROE 12.26%
ROIC 8.78%
ROA(3y)9.43%
ROA(5y)9.2%
ROE(3y)16.48%
ROE(5y)16.07%
ROIC(3y)10.77%
ROIC(5y)10.86%
IEX Yearly ROA, ROE, ROICIEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

IEX's Profit Margin of 14.60% is amongst the best of the industry. IEX outperforms 85.83% of its industry peers.
In the last couple of years the Profit Margin of IEX has declined.
IEX's Operating Margin of 21.13% is amongst the best of the industry. IEX outperforms 91.34% of its industry peers.
IEX's Operating Margin has declined in the last couple of years.
The Gross Margin of IEX (44.38%) is better than 82.68% of its industry peers.
IEX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.13%
PM (TTM) 14.6%
GM 44.38%
OM growth 3Y-3.35%
OM growth 5Y-2.38%
PM growth 3Y-1.68%
PM growth 5Y-1.96%
GM growth 3Y-0.06%
GM growth 5Y-0.4%
IEX Yearly Profit, Operating, Gross MarginsIEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IEX is still creating some value.
Compared to 1 year ago, IEX has more shares outstanding
IEX has less shares outstanding than it did 5 years ago.
The debt/assets ratio for IEX is higher compared to a year ago.
IEX Yearly Shares OutstandingIEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IEX Yearly Total Debt VS Total AssetsIEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 4.78 indicates that IEX is not in any danger for bankruptcy at the moment.
IEX has a better Altman-Z score (4.78) than 75.59% of its industry peers.
IEX has a debt to FCF ratio of 3.48. This is a good value and a sign of high solvency as IEX would need 3.48 years to pay back of all of its debts.
The Debt to FCF ratio of IEX (3.48) is better than 62.99% of its industry peers.
IEX has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
IEX has a Debt to Equity ratio of 0.47. This is comparable to the rest of the industry: IEX outperforms 48.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.48
Altman-Z 4.78
ROIC/WACC0.92
WACC9.57%
IEX Yearly LT Debt VS Equity VS FCFIEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

IEX has a Current Ratio of 2.79. This indicates that IEX is financially healthy and has no problem in meeting its short term obligations.
IEX has a Current ratio of 2.79. This is in the better half of the industry: IEX outperforms 73.23% of its industry peers.
IEX has a Quick Ratio of 1.99. This is a normal value and indicates that IEX is financially healthy and should not expect problems in meeting its short term obligations.
IEX's Quick ratio of 1.99 is fine compared to the rest of the industry. IEX outperforms 74.80% of its industry peers.
Industry RankSector Rank
Current Ratio 2.79
Quick Ratio 1.99
IEX Yearly Current Assets VS Current LiabilitesIEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

5

3. Growth

3.1 Past

IEX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.25%.
IEX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.36% yearly.
Looking at the last year, IEX shows a small growth in Revenue. The Revenue has grown by 1.66% in the last year.
IEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.55% yearly.
EPS 1Y (TTM)-3.25%
EPS 3Y7.74%
EPS 5Y6.36%
EPS Q2Q%-6.91%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y5.74%
Revenue growth 5Y5.55%
Sales Q2Q%1.72%

3.2 Future

Based on estimates for the next years, IEX will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.51% on average per year.
IEX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.93% yearly.
EPS Next Y5.12%
EPS Next 2Y6.6%
EPS Next 3Y6.95%
EPS Next 5Y11.51%
Revenue Next Year4.81%
Revenue Next 2Y4.43%
Revenue Next 3Y4.98%
Revenue Next 5Y8.93%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IEX Yearly Revenue VS EstimatesIEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B 5B
IEX Yearly EPS VS EstimatesIEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 23.66, the valuation of IEX can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of IEX is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.50, IEX is valued at the same level.
With a Price/Forward Earnings ratio of 20.48, IEX is valued on the expensive side.
IEX's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of IEX to the average of the S&P500 Index (36.44), we can say IEX is valued slightly cheaper.
Industry RankSector Rank
PE 23.66
Fwd PE 20.48
IEX Price Earnings VS Forward Price EarningsIEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

IEX's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as IEX.
Industry RankSector Rank
P/FCF 24.83
EV/EBITDA 17.36
IEX Per share dataIEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IEX does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of IEX may justify a higher PE ratio.
PEG (NY)4.63
PEG (5Y)3.72
EPS Next 2Y6.6%
EPS Next 3Y6.95%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.54%, IEX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.83, IEX pays a bit more dividend than its industry peers.
IEX's Dividend Yield is slightly below the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 1.54%

5.2 History

The dividend of IEX is nicely growing with an annual growth rate of 6.95%!
IEX has paid a dividend for at least 10 years, which is a reliable track record.
IEX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)6.95%
Div Incr Years15
Div Non Decr Years29
IEX Yearly Dividends per shareIEX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

43.67% of the earnings are spent on dividend by IEX. This is a bit on the high side, but may be sustainable.
The dividend of IEX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.67%
EPS Next 2Y6.6%
EPS Next 3Y6.95%
IEX Yearly Income VS Free CF VS DividendIEX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
IEX Dividend Payout.IEX Dividend Payout, showing the Payout Ratio.IEX Dividend Payout.PayoutRetained Earnings

IDEX CORP

NYSE:IEX (7/18/2025, 8:04:00 PM)

After market: 183.38 0 (0%)

183.38

-0.58 (-0.32%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-30 2025-07-30/amc
Inst Owners102.46%
Inst Owner Change0%
Ins Owners0.18%
Ins Owner Change3.91%
Market Cap13.85B
Analysts76.84
Price Target213.98 (16.69%)
Short Float %3.24%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield 1.54%
Yearly Dividend2.71
Dividend Growth(5Y)6.95%
DP43.67%
Div Incr Years15
Div Non Decr Years29
Ex-Date07-11 2025-07-11 (0.71)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.99%
Min EPS beat(2)-0.11%
Max EPS beat(2)6.08%
EPS beat(4)1
Avg EPS beat(4)1.41%
Min EPS beat(4)-0.18%
Max EPS beat(4)6.08%
EPS beat(8)5
Avg EPS beat(8)3.35%
EPS beat(12)9
Avg EPS beat(12)3.49%
EPS beat(16)11
Avg EPS beat(16)3.14%
Revenue beat(2)0
Avg Revenue beat(2)-0.61%
Min Revenue beat(2)-1.1%
Max Revenue beat(2)-0.12%
Revenue beat(4)0
Avg Revenue beat(4)-1.2%
Min Revenue beat(4)-3.45%
Max Revenue beat(4)-0.12%
Revenue beat(8)1
Avg Revenue beat(8)-0.97%
Revenue beat(12)5
Avg Revenue beat(12)0.48%
Revenue beat(16)7
Avg Revenue beat(16)0.56%
PT rev (1m)0%
PT rev (3m)-8.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.92%
EPS NY rev (1m)-0.11%
EPS NY rev (3m)-0.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.2%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 23.66
Fwd PE 20.48
P/S 4.22
P/FCF 24.83
P/OCF 22.44
P/B 3.55
P/tB N/A
EV/EBITDA 17.36
EPS(TTM)7.75
EY4.23%
EPS(NY)8.95
Fwd EY4.88%
FCF(TTM)7.38
FCFY4.03%
OCF(TTM)8.17
OCFY4.46%
SpS43.46
BVpS51.72
TBVpS-8.58
PEG (NY)4.63
PEG (5Y)3.72
Profitability
Industry RankSector Rank
ROA 7.05%
ROE 12.26%
ROCE 11.16%
ROIC 8.78%
ROICexc 9.71%
ROICexgc 51.33%
OM 21.13%
PM (TTM) 14.6%
GM 44.38%
FCFM 16.99%
ROA(3y)9.43%
ROA(5y)9.2%
ROE(3y)16.48%
ROE(5y)16.07%
ROIC(3y)10.77%
ROIC(5y)10.86%
ROICexc(3y)11.91%
ROICexc(5y)12.81%
ROICexgc(3y)60.63%
ROICexgc(5y)61.29%
ROCE(3y)13.7%
ROCE(5y)13.82%
ROICexcg growth 3Y-3.1%
ROICexcg growth 5Y-4.49%
ROICexc growth 3Y-11.38%
ROICexc growth 5Y-9.81%
OM growth 3Y-3.35%
OM growth 5Y-2.38%
PM growth 3Y-1.68%
PM growth 5Y-1.96%
GM growth 3Y-0.06%
GM growth 5Y-0.4%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.48
Debt/EBITDA 2.09
Cap/Depr 32.16%
Cap/Sales 1.81%
Interest Coverage 11.44
Cash Conversion 70.28%
Profit Quality 116.43%
Current Ratio 2.79
Quick Ratio 1.99
Altman-Z 4.78
F-Score5
WACC9.57%
ROIC/WACC0.92
Cap/Depr(3y)51%
Cap/Depr(5y)57.05%
Cap/Sales(3y)2.29%
Cap/Sales(5y)2.34%
Profit Quality(3y)102.65%
Profit Quality(5y)110.92%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.25%
EPS 3Y7.74%
EPS 5Y6.36%
EPS Q2Q%-6.91%
EPS Next Y5.12%
EPS Next 2Y6.6%
EPS Next 3Y6.95%
EPS Next 5Y11.51%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y5.74%
Revenue growth 5Y5.55%
Sales Q2Q%1.72%
Revenue Next Year4.81%
Revenue Next 2Y4.43%
Revenue Next 3Y4.98%
Revenue Next 5Y8.93%
EBIT growth 1Y-3.88%
EBIT growth 3Y2.2%
EBIT growth 5Y3.04%
EBIT Next Year31.25%
EBIT Next 3Y13.88%
EBIT Next 5Y15.19%
FCF growth 1Y1.96%
FCF growth 3Y6.97%
FCF growth 5Y4.79%
OCF growth 1Y-1.34%
OCF growth 3Y5.73%
OCF growth 5Y4.82%